Stay updated with breaking news from Nasdaq Ljpc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com began coverage on shares of La Jolla Pharmaceutical (NASDAQ:LJPC – Get Rating) in a research note issued to investors on Thursday. The firm set a “buy” rating on the biopharmaceutical company’s stock. Separately, Zacks Investment Research downgraded La Jolla Pharmaceutical from a “buy” rating to a “hold” rating in a report on Wednesday, January […]
La Jolla Pharmaceutical (NASDAQ:LJPC – Get Rating) crossed above its fifty day moving average during trading on Monday . The stock has a fifty day moving average of $4.29 and traded as high as $4.34. La Jolla Pharmaceutical shares last traded at $4.24, with a volume of 55,115 shares. Several analysts have issued reports on […]
Hollencrest Capital Management grew its stake in shares of La Jolla Pharmaceutical (NASDAQ:LJPC – Get Rating) by 94.4% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 82,355 shares of the biopharmaceutical company’s stock after acquiring an additional 40,000 […]